Zhang Q, Friedman P
Int J Mol Sci. 2021; 22(20).
PMID: 34681624
PMC: 8535999.
DOI: 10.3390/ijms222010963.
Nardella C, Visconti L, Malagrino F, Pagano L, Bufano M, Nalli M
Biol Direct. 2021; 16(1):15.
PMID: 34641953
PMC: 8506081.
DOI: 10.1186/s13062-021-00303-9.
Coluccia A, La Regina G, Naccarato V, Nalli M, Orlando V, Biagioni S
ACS Med Chem Lett. 2019; 10(4):499-503.
PMID: 30996786
PMC: 6466550.
DOI: 10.1021/acsmedchemlett.8b00532.
Saponaro C, Sergio S, Coluccia A, De Luca M, La Regina G, Mologni L
Oncogene. 2018; 37(24):3301-3316.
PMID: 29551770
PMC: 6002344.
DOI: 10.1038/s41388-018-0170-y.
Georgescu M, Gagea M, Cote G
Neoplasia. 2016; 18(8):512-23.
PMID: 27566107
PMC: 5018097.
DOI: 10.1016/j.neo.2016.07.003.
NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
Georgescu M, Mobley B, Orr B, Shang P, Lehman N, Zhu X
Acta Neuropathol Commun. 2016; 4(1):55.
PMID: 27229317
PMC: 4882843.
DOI: 10.1186/s40478-016-0329-0.
Small molecule inhibition of the Na(+)/H(+) exchange regulatory factor 1 and parathyroid hormone 1 receptor interaction.
Fitzpatrick J, Pellegrini M, Cushing P, Mierke D
Biochemistry. 2014; 53(37):5916-22.
PMID: 25171053
PMC: 4172209.
DOI: 10.1021/bi500368k.
Accidental interaction between PDZ domains and diclofenac revealed by NMR-assisted virtual screening.
Tenno T, Goda N, Umetsu Y, Ota M, Kinoshita K, Hiroaki H
Molecules. 2013; 18(8):9567-81.
PMID: 23966078
PMC: 6270271.
DOI: 10.3390/molecules18089567.
An in silico analysis of the binding modes and binding affinities of small molecule modulators of PDZ-peptide interactions.
Tiwari G, Mohanty D
PLoS One. 2013; 8(8):e71340.
PMID: 23951139
PMC: 3738590.
DOI: 10.1371/journal.pone.0071340.
Development of a high-throughput screening-compatible assay for the discovery of inhibitors of the AF4-AF9 interaction using AlphaScreen technology.
Watson V, Drake K, Peng Y, Napper A
Assay Drug Dev Technol. 2013; 11(4):253-68.
PMID: 23679849
PMC: 3656630.
DOI: 10.1089/adt.2012.495.
NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains.
Cardone R, Greco M, Capulli M, Weinman E, Busco G, Bellizzi A
Mol Biol Cell. 2012; 23(11):2028-40.
PMID: 22496422
PMC: 3364169.
DOI: 10.1091/mbc.E11-11-0911.
Structural basis for NHERF1 PDZ domain binding.
Mamonova T, Kurnikova M, Friedman P
Biochemistry. 2012; 51(14):3110-20.
PMID: 22429102
PMC: 3323774.
DOI: 10.1021/bi201213w.
Engineering peptide inhibitors to overcome PDZ binding promiscuity.
Vouilleme L, Cushing P, Volkmer R, Madden D, Boisguerin P
Angew Chem Int Ed Engl. 2010; 49(51):9912-6.
PMID: 21105032
PMC: 3037833.
DOI: 10.1002/anie.201005575.
Na+/H+ exchanger regulatory factor-1 is involved in chemokine receptor homodimer CCR5 internalization and signal transduction but does not affect CXCR4 homodimer or CXCR4-CCR5 heterodimer.
Hammad M, Kuang Y, Yan R, Allen H, Dupre D
J Biol Chem. 2010; 285(45):34653-64.
PMID: 20801883
PMC: 2966081.
DOI: 10.1074/jbc.M110.106591.
Structure-activity relationships of a small-molecule inhibitor of the PDZ domain of PICK1.
Bach A, Stuhr-Hansen N, Thorsen T, Bork N, Moreira I, Frydenvang K
Org Biomol Chem. 2010; 8(19):4281-8.
PMID: 20668766
PMC: 3614091.
DOI: 10.1039/c0ob00025f.
GLAST stability and activity are enhanced by interaction with the PDZ scaffold NHERF-2.
Ritter S, Asay M, Paquet M, Paavola K, Reiff R, Yun C
Neurosci Lett. 2010; 487(1):3-7.
PMID: 20430067
PMC: 2923238.
DOI: 10.1016/j.neulet.2010.04.043.
Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD.
Thorsen T, Madsen K, Rebola N, Rathje M, Anggono V, Bach A
Proc Natl Acad Sci U S A. 2009; 107(1):413-8.
PMID: 20018661
PMC: 2806717.
DOI: 10.1073/pnas.0902225107.